Charts
Plenary Session - inactive due to federal serviceEpisode from the podcastPlenary Session - inactive due to federal service
CABINET - trial - Cabozantinib for NET

CABINET - trial - Cabozantinib for NET

Released Thursday, 20th February 2025
Good episode? Give it some love!
CABINET - trial - Cabozantinib for NET

CABINET - trial - Cabozantinib for NET

CABINET - trial - Cabozantinib for NET

CABINET - trial - Cabozantinib for NET

Thursday, 20th February 2025
Good episode? Give it some love!
Rate Episode
List
About
InsightsPodchaser Pro
Reviews
Credits
Lists
Transcript

Back to basics as I break down a trial

Show More
Rate
List
Get this podcast via API

From The Podcast

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco.Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more
Do you host or manage this podcast?
Claim and edit this page to your liking.
,
Podchaser Logo

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More